Fundraising Fox
/Companies
Sign in

Avantguardinc

2 known investors

Find your way into Avantguardinc

Sign up to see every warm intro you have to Avantguardinc

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Avantguardinc team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AvantGuard, a Cornell University spin-out originally founded as Halomine, develops N-halamine-based antimicrobial and surface-protection technology aimed at combating pathogens including the fungus Candida (Candidozyma) auris. The company is advancing an antifungal decolonization protocol toward FDA approval, targeting fungal skin and nail infections and healthcare antiseptic applications.

BiotechHealthtechNew Materials

Founders & leadership

ES
Edward S. EvelethCEO
MHMarc Hein
Marc HeinCTOMarc Hein is CTO of AvantGuard, a Cornell University spin-out developing antimicrobial surface-protection technology. He has held roles spanning strategic marketing, product development, R&D, and manufacturing across multiple industries.
MNMichael Newell
Michael NewellVP of Sales and MarketingMichael Newell has spent over 40 years in sales, marketing, and business development leadership roles across healthcare and environmental technology companies in North America, Europe, China, and Japan, including positions at Empire State Health Solutions, IDEX, Rheodyne, Inficon, AT&T Capital, and US Analytical Instruments. He serves as VP of Sales and Marketing at AvantGuard (formerly Halomine), a Cornell spin-out developing N-halamine-based antimicrobial surface-protection technology.
CN
Carine NkemngongDirector of Microbiology and Disinfectants

Investors · 2

SOSVlisted by SOSVNew York · $30K – $550K

How we know: sosv.com · Not right? Tell us

Related companies · 1

HealthPartnersHealthPartners is a health system and health insurance organization that provides medical care and coverage while working to reduce health disparities in the communities it serves. It focuses on advancing health equity in chronic disease care, preventive screenings, and maternal and child health.

Companies working in the same space as Avantguardinc.

Frequently asked questions

What does Avantguardinc do?
AvantGuard, a Cornell University spin-out originally founded as Halomine, develops N-halamine-based antimicrobial and surface-protection technology aimed at combating pathogens including the fungus Candida (Candidozyma) auris. The company is advancing an antifungal decolonization protocol toward FDA approval, targeting fungal skin and nail infections and healthcare antiseptic applications.
Who are Avantguardinc's investors?
Avantguardinc's investors include Launch NY, SOSV.